Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta
Introduction: Treatment with orally administered ibandronate is an effective way to increase bone mineral density (BMD) and reduce fracture rate in post-menopausal women and in men with osteoporosis. There are only very few reports concerning ibandronate therapy in children and adolescents, and in p...
Guardado en:
Autores principales: | Štěpán Kutílek, Ivana Plášilová, Sylva Skálová, Milan Bayer, Erika Ondrušová |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Karolinum Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da761f76a1dc43e59a780af449ac0dc5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phenotypic Properties of Collagen in Dentinogenesis Imperfecta Associated with Osteogenesis Imperfecta
por: Ibrahim S, et al.
Publicado: (2019) -
Compromiso auditivo en osteogénesis imperfecta
por: Royer F,Michel, et al.
Publicado: (2006) -
Observed Frequency and Characteristics of Hearing Loss in Osteogenesis Imperfecta
por: Waissbluth,Sofia, et al.
Publicado: (2020) -
In vivo laser confocal microscopy findings of a cornea with osteogenesis imperfecta
por: Kobayashi A, et al.
Publicado: (2014) -
Fracturas vertebrales en niños con osteogénesis imperfecta tipo I
por: Sepúlveda,Andrea M, et al.
Publicado: (2017)